Daiichi Sankyo (United States)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
52%
Total
Publications
1.4K
Total Open
Publications
722
Total
Citations
45K
Open Access
Percentage
52%
Total
Publications
1.4K
Total Open
Publications
722
Total
Citations
45K
Breakdown
Publisher Open
27%
Both
20%
Other Platform Open
5%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 21%
134
Hybrid 41%
268
No Guarantees 38%
247
Other Platform Open
Domain 82%
284
Institution 23%
79
Public 13%
46
Other Internet 8%
27
Preprint 6%
22
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 283 |
Europe PMC | Domain | 121 |
Semantic Scholar | Public | 34 |
Figshare | Public | 30 |
DOI | Other Internet | 24 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 13 |
University College London - UCL Discovery | Institution | 11 |
Research Square | Preprint | 11 |
Radboud University - Radboud Repository | Institution | 11 |
KU Leuven - Lirias | Institution | 11 |